Clinical Trial Update: OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder [NA]

View source ↗

Summary

Clinical trial update shows completion of a study evaluating OXD01 in combination with sublingual buprenorphine/naloxone for opioid use disorder, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)
• OXD01

Snippet

Sponsor: Orexo AB | Conditions: Opioid-use Disorder | NA | Status: COMPLETED | Results posted: 2025-06-27